Structured evidence table for Ginkgo Memory Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Ginkgo Memory Randomized Trial | Aburto et al., 2020 Gaspar-Silva et al., 2023 Maldonado Briegas et al., 2020 Life expectancy has increased markedly since the last century, leading to a rapidly expanding elderly population globally. | 2 | Gao Yuhong (2026) | Cistanche tubulosa - Ginkgo biloba combination enhances memory via cortico-cerebellar reorganization: a randomized controlled trial |
| Ginkgo Memory Randomized Trial | Similarly, a meta-analysis of 23 RCTs found that creatine supplementation improved memory in healthy individuals, particularly in older adults aged 66–76 years (). | 2 | Gao Yuhong (2026) | Cistanche tubulosa - Ginkgo biloba combination enhances memory via cortico-cerebellar reorganization: a randomized controlled trial |
| Ginkgo Memory Randomized Trial | (5) portrait memory (PM): Participants memorized and later recalled details (name, occupation, preferences) associated with six portraits. | 2 | Gao Yuhong (2026) | Cistanche tubulosa - Ginkgo biloba combination enhances memory via cortico-cerebellar reorganization: a randomized controlled trial |
| Ginkgo Memory Randomized Trial | This demographic shift underscores the urgent need to address age-related health challenges, particularly cognitive decline, as a critical public health priority (). | 2 | Gao Yuhong (2026) | Cistanche tubulosa - Ginkgo biloba combination enhances memory via cortico-cerebellar reorganization: a randomized controlled trial |
| Ginkgo Memory Randomized Trial | In addition, an overview of systematic reviews synthesized the broader EGb 761 evidence base across indications and highlighted that conclusions require caution given the methodological limitations of many reviews []. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
| Ginkgo Memory Randomized Trial | Real-world observational analyses have also reported associations between prescriptions of Ginkgo leaf extract and reduced risk of dementia severity progression, albeit with the inherent limitations of non-randomized designs []. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
| Ginkgo Memory Randomized Trial | Accordingly, this review revisits the historical evidence base with explicit attention to heterogeneity and methodological design, and then examines biomarker-confirmed AD-spectrum studies as a potential pivot point. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
| Ginkgo Memory Randomized Trial | 1 2 Alzheimer’s disease (AD) remains the most common cause of dementia and continues to impose a major burden on patients, caregivers, and healthcare systems []. | 3 | Yang YoungSoon (2026) | Ginkgo Biloba for Alzheimer’s Disease: From Mixed Dementia Trials to Biomarker-Confirmed Mild Cognitive Impairment—What Have We Learned over Two Decades, and Is There Finally a Bit of Hope? |
Source documents